Bellevue Group AG - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$888,030
-10.6%
33,0000.0%0.01%0.0%
Q2 2023$993,630
-6.9%
33,0000.0%0.01%
-6.7%
Q1 2023$1,067,550
+102.4%
33,000
+79.3%
0.02%
+114.3%
Q4 2022$527,344
+63.3%
18,400
+37.3%
0.01%
+40.0%
Q3 2022$323,000
-12.0%
13,4000.0%0.01%0.0%
Q2 2022$367,000
-28.6%
13,4000.0%0.01%
-16.7%
Q1 2022$514,00013,4000.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders